aTyr Pharma | LIFE - Equity Capital And Reserves


aTyr Pharma reported $80.24M in Equity Capital and Reserves for its fiscal quarter ending in September of 2025.





Equity Capital And Reserves Change Date
Ardelyx USD 154.28M 14.75M Sep/2025
aTyr Pharma USD 80.24M 5.58M Sep/2025
Biogen USD 18.21B 573.5M Sep/2025
Bristol-Myers Squibb USD 18.55B 1.06B Sep/2025
Cipla INR 329.19B 16.3B Sep/2025
Clal Biotechnology ILS 121.41M 4.62M Dec/2023
Compugen USD 43.83M 6.43M Sep/2025
CSL USD 21.41B 861M Jun/2025
Galapagos EUR 2.45B 196.86M Sep/2025
GlaxoSmithKline GBP 16.38B 229M Dec/2025
Grifols EUR 6.08B 34.72M Sep/2025
Novartis USD 44.75B 2.7B Sep/2025
Roche Holding CHF 33.8B 758M Dec/2025
United Therapeutics USD 6.59B 583.4M Sep/2025